Author Contributions Conceived and designed the experiments: JNC BC SHL HSK SWK. Performed the experiments: JNC BC KWL DJL DHK JYL ISS HIK SHL References 1. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301–310. 2. Simmons MJ, Fan G, Zong WX, Degenhardt K, White E, et al. (2008) Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene 27: 1421–1428. 3. Bubici C, Papa S, Dean K, Franzoso G (2006) Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25: 6731–6748. 4. Wang CY, Guttridge DC, Mayo MW, Baldwin AS, Jr. (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19: 5923–5929. 5. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621–663. 6. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195–2224. 7. Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309–313. 8. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (1997) IkappaB kinase- beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278: 866–869. 9. Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385: 540–544. 10. Lee FS, Peters RT, Dang LC, Maniatis T (1998) MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc Natl Acad Sci U S A 95: 9319–9324. 11. Zhao Q, Lee FS (1999) Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. J Biol Chem 274: 8355–8358. 12. Yang J, Lin Y, Guo Z, Cheng J, Huang J, et al. (2001) The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2: 620–624. 13. Hu MC, Wang Y, Qiu WR, Mikhail A, Meyer CF, et al. (1999) Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase. Oncogene 18: 5514–5524. 14. Hehner SP, Hofmann TG, Ushmorov A, Dienz O, Wing-Lan Leung I, et al. (2000) Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol 20: 2556–2568. 15. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, et al. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346–351. 16. Heyninck K, Beyaert R (2005) A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 30: 1–4. 17. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-kappaB activation. Nat Cell Biol 8: 398–406. 18. Zhou H, Wertz I, O’Rourke K, Ultsch M, Seshagiri S, et al. (2004) Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427: 167–171. 19. Broemer M, Krappmann D, Scheidereit C (2004) Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. Oncogene 23: 5378–5386. 20. Chen G, Cao P, Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9: 401–410. 21. Park KJ, Gaynor RB, Kwak YT (2003) Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF- kappa B activation. J Biol Chem 278: 35272–35278. 22. Ran R, Lu A, Zhang L, Tang Y, Zhu H, et al. (2004) Hsp70 promotes TNF- mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev 18: 1466–1481. 23. Prajapati S, Verma U, Yamamoto Y, Kwak YT, Gaynor RB (2004) Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity. J Biol Chem 279: 1739–1746. 24. Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F, et al. (2004) Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 304: 1963–1967. 25. Cappello F, de Macario EC, Marasa L, Zummo G, Macario AJ (2008) Hsp60 expression, new locations, functions, and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 7. 26. Calderwood SK, Mambula SS, Gray PJ, Jr. (2007) Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 1113: 28–39. 27. Kirchhoff SR, Gupta S, Knowlton AA (2002) Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 105: 2899–2904. 28. Xanthoudakis S, Roy S, Rasper D, Hennessey T, Aubin Y, et al. (1999) Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. Embo J 18: 2049–2056. Hsp60 for IKK Regulation HSK NKL. Analyzed the data: JNC BC KWL DJL DHK JYL ISS HIK SHL HSK SYL KJL JK SWK. Contributed reagents/materials/analysis tools: SYL. Wrote the paper: JK SWK. 29. Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S (1999) Presence of a pre- apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. Embo J 18: 2040–2048. 30. Beere HM (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115: 2633–2639. 31. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, et al. (2003) A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659–663. 32. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655–659. 33. Cogswell PC, Kashatus DF, Keifer JA, Guttridge DC, Reuther JY, et al. (2003) NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B. J Biol Chem 278: 2963–2968. 34. Bozner P, Wilson GL, Druzhyna NM, Bryant-Thomas TK, LeDoux SP, et al. (2002) Deficiency of chaperonin 60 in Down’s syndrome. J Alzheimers Dis 4: 479–486. 35. Briones P, Vilaseca MA, Ribes A, Vernet A, Lluch M, et al. (1997) A new case of multiple mitochondrial enzyme deficiencies with decreased amount of heat shock protein 60. J Inherit Metab Dis 20: 569–577. 36. Huckriede A, Heikema A, Sjollema K, Briones P, Agsteribbe E (1995) Morphology of the mitochondria in heat shock protein 60 deficient fibroblasts from mitochondrial myopathy patients. Effects of stress conditions. Virchows Arch 427: 159–165. 37. Park SG, Lee SM, Jung G (2003) Antisense oligodeoxynucleotides targeted against molecular chaperonin Hsp60 block human hepatitis B virus replication. J Biol Chem 278: 39851–39857. 38. Steinhoff U, Zugel U, Wand-Wurttenberger A, Hengel H, Rosch R, et al. (1994) Prevention of autoimmune lysis by T cells with specificity for a heat shock protein by antisense oligonucleotide treatment. Proc Natl Acad Sci U S A 91: 5085–5088. 39. Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19: 1173–1176. 40. Horovitz A, Bochkareva ES, Girshovich AS (1993) The N terminus of the molecular chaperonin GroEL is a crucial structural element for its assembly. J Biol Chem 268: 9957–9959. 41. White ZW, Fisher KE, Eisenstein E (1995) A monomeric variant of GroEL binds nucleotides but is inactive as a molecular chaperone. J Biol Chem 270: 20404–20409. 42. Bukau B, Horwich AL (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92: 351–366. 43. Rye HS, Burston SG, Fenton WA, Beechem JM, Xu Z, et al. (1997) Distinct actions of cis and trans ATP within the double ring of the chaperonin GroEL. Nature 388: 792–798. 44. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. (1998) NF- kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683. 45. Kokoszka JE, Coskun P, Esposito LA, Wallace DC (2001) Increased mitochondrial oxidative stress in the Sod2 (+/2) mouse results in the age- related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci U S A 98: 2278–2283. 46. Kamata H, Honda S, Maeda S, Chang L, Hirata H, et al. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649–661. 47. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, et al. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222–228. 48. Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977–990. 49. Wong GH, Elwell JH, Oberley LW, Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923–931. 50. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, et al. (1999) Limb and skin abnormalities in mice lacking IKKalpha. Science 284: 313–316. 51. Tanaka T, Ohkubo S, Tatsuno I, Prives C (2007) hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 130: 638–650. 52. Scheidereit C (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685–6705. 53. Hoberg JE, Yeung F, Mayo MW (2004) SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell 16: 245–255. PLoS ONE | www.plosone.org 15 March 2010 | Volume 5 | Issue 3 | e9422